The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Exosomes Secreted by Human Placenta Carry Functional Fas Ligand and TRAIL Molecules and Convey Apoptosis in Activated Immune Cells, Suggesting Exosome-Mediated Immune Privilege of the Fetus
Abstract
Apoptosis is crucially important in mediating immune privilege of the fetus during pregnancy. We investigated the expression and in vitro apoptotic activity of two physiologically relevant death messengers, the TNF family members Fas ligand (FasL) and TRAIL in human early and term placentas. Both molecules were intracellularly expressed, confined to the late endosomal compartment of the syncytiotrophoblast, and tightly associated to the generation and secretion of placental exosomes. Using immunoelectron microscopy, we show that FasL and TRAIL are expressed on the limiting membrane of multivesicular bodies where, by membrane invagination, intraluminal microvesicles carrying membranal bioactive FasL and TRAIL are formed and released in the extracellular space as exosomes. Analyzing exosomes secreted from placental explant cultures, to our knowledge, we demonstrate for the first time that FasL and TRAIL are clustered on the exosomal membrane as oligomerized aggregates ready to form death-inducing signaling complex. Consistently, placental FasL- and TRAIL-carrying exosomes triggered apoptosis in Jurkat T cells and activated PBMC in a dose-dependent manner. Limiting the expression of functional FasL and TRAIL to exosomes comprise a dual benefit: 1) storage of exosomal FasL and TRAIL in multivesicular bodies is protected from proteolytic cleavage and 2) upon secretion, delivery of preformed membranal death molecules by exosomes rapidly triggers apoptosis. Our results suggest that bioactive FasL- and TRAIL-carrying exosomes, able to convey apoptosis, are secreted by the placenta and tie up the immunomodulatory and protective role of human placenta to its exosome-secreting ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling
Taylor, D. D., Akyol, S., & Gercel-Taylor, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1534 · Cited by 297
RetractedInayat, M. S., Damodaran, C., Mohiuddin, M., Elford, H. L., Gallicchio, V. S., & Ahmed, M. M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.174 · Cited by 100
RetractedDeath Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., & Tschopp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1205 · Cited by 812
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Production and characterization of clinical grade exosomes derived from dendritic cells
Lamparski, H. G., Metha-Damani, A., Yao, J.-Y., Patel, S., Hsu, D.-H., Ruegg, C., & Le Pecq, J.-B. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00330-7 · Cited by 700
Exosomes: immune properties and potential clinical implementations
Chaput, N., & Théry, C. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-010-0233-9 · Cited by 560
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508
Knight, M., Redman, C. W. G., Linton, E. A., & Sargent, I. L. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10178.x · Cited by 494
Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
Griffith, T. S., Wiley, S. R., Kubin, M. Z., Sedger, L. M., Maliszewski, C. R., & Fanger, N. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1343 · Cited by 476
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
Holler, N., Tardivel, A., Kovacsovics-Bankowski, M., Hertig, S., Gaide, O., Martinon, F., Tinel, A., Deperthes, D., Calderara, S., Schulthess, T., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1428-1440.2003 · Cited by 406
Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta
Huppertz, B., Frank, H.-G., Kingdom, J. C. P., Reister, F., & Kaufmann, P. (1998) · Histochemistry and Cell Biology · doi:10.1007/s004180050311 · Cited by 402
Bossi, G., & Griffiths, G. M. (1999) · Nature Medicine · doi:10.1038/4779 · Cited by 387
Allison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Munich, S., Sobo-Vujanovic, A., Buchser, W. J., Beer-Stolz, D., & Vujanovic, N. L. (2012) · OncoImmunology · doi:10.4161/onci.20897 · Cited by 360
Hedlund, M., Stenqvist, A.-C., Nagaeva, O., Kjellberg, L., Wulff, M., Baranov, V., & Mincheva-Nilsson, L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803477 · Cited by 332
Self-citationPlacental Apoptosis in Health and Disease
Sharp, A. N., Heazell, A. E. P., Crocker, I. P., & Mor, G. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00837.x · Cited by 325
Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles
Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., Piñeiro, A., Alava, M. A., & Naval, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1274 · Cited by 307
The role of Fas ligand in immune privilege
Green, D. R., & Ferguson, T. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103104 · Cited by 284
Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., Piñeiro, A., Larrad, L., Alava, M. A., Naval, J., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6736 · Cited by 266
A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAIL
Hymowitz, S. G., O'Connell, M. P., Ultsch, M. H., Hurst, A., Totpal, K., Ashkenazi, A., de Vos, A. M., & Kelley, R. F. (2000) · Biochemistry · doi:10.1021/bi992242l · Cited by 261
First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis
Abrahams, V. M. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah006 · Cited by 254
Hohlbaum, A. M., Moe, S., & Marshak-Rothstein, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1209 · Cited by 241
REVIEW ARTICLE: The Role of Placental Exosomes in Reproduction
Mincheva‐Nilsson, L., & Baranov, V. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00822.x · Cited by 217
Self-citationWajant, H., Moosmayer, D., Wüest, T., Bartke, T., Gerlach, E., Schönherr, U., Peters, N., Scheurich, P., & Pfizenmaier, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204558 · Cited by 212
Mincheva-Nilsson, L., Nagaeva, O., Chen, T., Stendahl, U., Antsiferova, J., Mogren, I., Hernestål, J., & Baranov, V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3585 · Cited by 198
Self-citationTRAIL (Apo-2L) and TRAIL Receptors in Human Placentas: Implications for Immune Privilege
Phillips, T. A., Ni, J., Pan, G., Ruben, S. M., Wei, Y.-F., Pace, J. L., & Hunt, J. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6053 · Cited by 189
Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity
Keng (2011) · Oncology Reports · doi:10.3892/or.2010.1119 · Cited by 180
Frängsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., & Mincheva-Nilsson, L. (2005) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gah129 · Cited by 179
Self-citationFas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail
Blott, E. J., Bossi, G., Clark, R., Zvelebil, M., & Griffiths, G. M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2405 · Cited by 159
The privileged immunity of immune privileged organs: the case of the eye
Benhar, I., London, A., & Schwartz, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00296 · Cited by 158
SNX1 Defines an Early Endosomal Recycling Exit for Sortilin and Mannose 6‐Phosphate Receptors
Mari, M., Bujny, M. V., Zeuschner, D., Geerts, W. J. C., Griffith, J., Petersen, C. M., Cullen, P. J., Klumperman, J., & Geuze, H. J. (2008) · Traffic · doi:10.1111/j.1600-0854.2007.00686.x · Cited by 156
Vargo-Gogola, T. C., Crawford, H. C., Fingleton, B., & Matrisian, L. M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00525-8 · Cited by 151
Alonso, R., Rodriguez, M. C., Pindado, J., Merino, E., Mérida, I., & Izquierdo, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501112200 · Cited by 135
Lünemann, J. D., Waiczies, S., Ehrlich, S., Wendling, U., Seeger, B., Kamradt, T., & Zipp, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4881 · Cited by 132
Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation
Zuccato, E., Blott, E. J., Holt, O. J., Sigismund, S., Shaw, M. K., Bossi, G., & Griffiths, G. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03315 · Cited by 123
Clayton, A., & Mason, M. D. (2009) · Current Oncology · doi:10.3747/co.v16i3.367 · Cited by 104
TRAIL: A Mechanism of Tumor Surveillance in an Immune Privileged Site
Lee, H., Herndon, J. M., Barreiro, R., Griffith, T. S., & Ferguson, T. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4739 · Cited by 104
Shudo, K., Ryu, I., & Shigekazu, N. (2003) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 89
Martínez‐Lorenzo, M. J., Anel, A., Álava, M. A., Piñeiro, A., Naval, J., Lasierra, P., & Larrad, L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.024 · Cited by 86
Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege
Gregory, M. S., Repp, A. C., Hohlbaum, A. M., Saff, R. R., Marshak‐Rothstein, A., & Ksander, B. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2727 · Cited by 84
Insights into the molecular regulation of FasL (CD178) biology
Lettau, M., Paulsen, M., Schmidt, H., & Janßen, O. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.006 · Cited by 78
Exploring death receptor pathways as selective targets in cancer therapy
Russo, M., Mupo, A., Spagnuolo, C., & Russo, G. L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.011 · Cited by 73
Expression of Fas-ligand in first trimester and term human placental villi
Hammer, A., & Dohr, G. (2000) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(99)00059-5 · Cited by 73
γδ T cells of human early pregnancy decidua: evidence for cytotoxic potency
Mincheva‐Nilsson, L., Nagaeva, O., Sundqvist, K., et al. (2000) · International Immunology · doi:10.1093/intimm/12.5.585 · Cited by 69
Self-citationOstler, T., & Ehl, S. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00191-6 · Cited by 68
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
Martínez‐Lostao, L., Marzo, I., Anel, A., & Naval, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.036 · Cited by 65
Posttranslational regulation of Fas ligand function
Voß, M., Lettau, M., Paulsen, M., & Janßen, O. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-11 · Cited by 52
Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis
Mor, G., Chavez, S. L., & Kamsteeg, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01267-4 · Cited by 50
CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies
Sträter, J., Walczak, H., Hasel, C., Melzner, I., Leithäuser, F., & Mӧller, P. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400813 · Cited by 48
A Placental Protective Role for Trophoblast-Derived TNF-Related Apoptosis-Inducing Ligand (TRAIL)
Bai, X., Williams, J., Greenwood, S. L., Baker, P. N., Aplin, J., & Crocker, I. P. (2009) · Placenta · doi:10.1016/j.placenta.2009.07.006 · Cited by 47
Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL
Martínez‐Lorenzo, M. J., Anel, A., Sáez, B., Royo‐Cañas, M., Bosque, A., Álava, M. A., Piñeiro, A., Lasierra, P., Asín-Ungría, J., & Larrad, L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.07.007 · Cited by 39
Stenqvist, A., Chen, T., Hedlund, M., Dimova, T., Nagaeva, O., Kjellberg, L., Innala, E., & Mincheva‐Nilsson, L. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00588.x · Cited by 36
Self-citationCancer cells use exosomes as tools to manipulate immunity and the microenvironment
Clayton, A. (2012) · OncoImmunology · doi:10.4161/onci.1.1.17826 · Cited by 35
Jodo, S., Hohlbaum, A. M., Xiao, S., Chan, D. V., Strehlow, D., Sherr, D. H., Marshak‐Rothstein, A., & Ju, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5487 · Cited by 34
Immune cells and molecules in pregnancy: friends or foes to the fetus?
Mincheva‐Nilsson, L. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.3.457 · Cited by 19
Self-citation
Cited by
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363
The roles of extracellular vesicles in the immune system
Buzas, E. I. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00763-8 · Cited by 1,220
Exosomes: Therapy delivery tools and biomarkers of diseases
Barile, L., & Vassalli, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.020 · Cited by 1,038
Metadata
- Authors
- Stenqvist, A.-C., Nagaeva, O., Baranov, V., & Mincheva-Nilsson, L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-01
- Volume
- 191
- Issue
- 11
- Pages
- 5515-5523
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2096185404
- Cited by
- 292
- References
- 59
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.